EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis

Antonio Molinaro iD, Lise Katrine Engesæter, Carl Jorns iD, Arno Nordin, Allan Rasmussen, Pål-Dag Line, Virge Pall, Bo-Göran Ericzon, William Bennet, Johannes R Hov iD, Espen Melum iD

Liver International · 2025

DOI: 10.1111/liv.16214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Antonio Molinaro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Liver Transplantation, Reoperation, Graft Survival. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-934173), ERC grant (no. 802544), Regional Healthy Authorities South-Eastern Norway (no. 2017022).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Primary sclerosing cholangitis (PSC) is among the most common indications for liver transplantation in the Nordic countries and with an increasing trend in Europe and North America. Due to post‐transplant complications and high prevalence of disease recurrence this group is at risk of requiring retransplantation (re‐LTX). Results from re‐LTX for PSC are not extensively studied and there is a lack of knowledge regarding prognosis after re‐LTX in this population.

Methods

Graft and patient survival after re‐LTX for patients with PSC and a comparable comparison group from the Nordic liver transplant registry were analysed. One‐hundred and eighty‐five patients with PSC and 208 patients in the comparison group were included.

Results

The graft and patient survival were better for patients with PSC compared to the comparison group ( p < 0.001). Re‐LTX for recurrence of PSC (rPSC) compared to other aetiologies had similar and better outcomes for graft and patient survival ( p = 0.093 and p = 0.023, respectively). Moreover, re‐LTX for rPSC compared to the comparison group had a lower 30‐day and 5‐year mortality ( p < 0.001 and p = 0.041, respectively).

Conclusion

Outcomes after retransplantation for PSC were similar or better compared to the comparison group. Retransplantation represents a treatment option with the potential for excellent outcomes in patients with PSC and should be considered in transplanted PSC patients with graft failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingLiver TransplantationReoperationGraft SurvivalRecurrenceHumansMaleFemaleAdultMiddle AgedTreatment OutcomeRegistriesScandinavian and Nordic CountriesRetrospective Studies

Stichwörter der Autor:innen

liver transplantationprimary sclerosing cholangitisretransplantation

Autor:innen und Institutionen

  • Department of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.
  • Norwegian PSC Research Center, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway.
  • Research Institute of Internal Medicine, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway.
  • Division of Transplantation Surgery, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Antonio Molinaro, Carl Jorns, Johannes R Hov, Espen Melum

Förderung

  • Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-934173)
  • ERC grant (no. 802544)
  • Regional Healthy Authorities South-Eastern Norway (no. 2017022)

Zitieren

APA

Molinaro, A., Engesæter, L. K., Jorns, C., Nordin, A., Rasmussen, A., Line, P. D., Pall, V., Ericzon, B. G., Bennet, W., Hov, J. R., & Melum, E. (2025). Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis. Liver International. https://doi.org/10.1111/liv.16214

Vancouver

Molinaro A, Engesæter LK, Jorns C, Nordin A, Rasmussen A, Line PD, et al. Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis. Liver International. 2025. doi:10.1111/liv.16214

BibTeX
@article{Molinaro2025,
  author = {Molinaro, Antonio and Engesæter, Lise Katrine and Jorns, Carl and Nordin, Arno and Rasmussen, Allan and Line, Pål-Dag and Pall, Virge and Ericzon, Bo-Göran and Bennet, William and Hov, Johannes R and Melum, Espen},
  title = {Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16214}
}
Kostenlos starten →